Patents by Inventor Stephen Will

Stephen Will has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230040046
    Abstract: Compositions, kits, and methods for performing rapid polymerase chain reaction (PCR) to amplify a target nucleic acid in a biological sample are disclosed. The methods include the use of at least one hybridization stabilizer and/or the adjustment of the thermocycling profiles between initiation and propagation phases of the amplification process. Also disclosed are methods of detecting the target nucleic acid following amplification thereof, as well as reaction mixtures that may be utilized in said methods.
    Type: Application
    Filed: January 5, 2021
    Publication date: February 9, 2023
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventor: Stephen Will
  • Publication number: 20220064947
    Abstract: This present application relates to a novel roof supporting system for use with outbuildings, such as gazebos, rotundas, and the like. The roof supporting system of the present invention eliminates the need for unsightly and architecturally limiting internal roof joists to account for the horizontal component of the live and dead roof loads transferred by the roofing rafters, and also eliminates the need for rafter tails to extend over the perimeter joist or wall members to create a roof with a clean edge appearance.
    Type: Application
    Filed: December 15, 2020
    Publication date: March 3, 2022
    Inventor: Stephen Will
  • Patent number: 10752891
    Abstract: Provided herein are methods and compositions to effectively isolate nucleic acids using protein-based sample collection matrices.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: August 25, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Stephen Will
  • Patent number: 10663379
    Abstract: A multi-layer plasma separation card comprising (a) a first layer including a sample receiving member comprising (i) a top planar surface for applying or receiving a blood sample, said sample receiving portion being adapted to permit contact of said blood sample with a separating member; and (ii) a bottom planar surface being adapted to contact said separating member, (b) a second layer including at least three separating members, each separating member being adapted to permit the passage of plasma to an absorptive member and comprising (i) a top planar surface for receiving said blood sample; and (ii) a bottom planar shield-shaped surface being adapted to contact said absorptive member, and (c) a third layer including at least two absorptive members for absorbing plasma from the bottom planar surface of each corresponding separating member and a backing member arranged in a manner to support said absorptive members, each absorptive member comprising a removable absorptive element having a top planar surface
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: May 26, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Siegfried Dick, Markus Fischer, Alexander Schmelzer, Andreas Trapp, Stephen Will
  • Publication number: 20170327815
    Abstract: Provided herein are methods and compositions to effectively isolate nucleic acids using protein-based sample collection matrices.
    Type: Application
    Filed: May 11, 2017
    Publication date: November 16, 2017
    Inventor: Stephen Will
  • Publication number: 20170067122
    Abstract: The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor.
    Type: Application
    Filed: November 4, 2016
    Publication date: March 9, 2017
    Inventors: Rachael Langland, Lin Wu, Thad Sharp, Stephen Will
  • Publication number: 20160290901
    Abstract: A multi-layer plasma separation card comprising (a) a first layer including a sample receiving member comprising (i) a top planar surface for applying or receiving a blood sample, said sample receiving portion being adapted to permit contact of said blood sample with a separating member; and (ii) a bottom planar surface being adapted to contact said separating member, (b) a second layer including at least three separating members, each separating member being adapted to permit the passage of plasma to an absorptive member and comprising (i) a top planar surface for receiving said blood sample; and (ii) a bottom planar shield-sharped surface being adapted to contact said absorptive member, and (c) a third layer including at least two absorptive members for absorbing plasma from the bottom planar surface of each corresponding separating member and a backing member arranged in a manner to support said absorptive members, each absorptive member comprising a removable absorptive element having a top planar surface
    Type: Application
    Filed: March 30, 2016
    Publication date: October 6, 2016
    Inventors: Siegfried Dick, Markus Fischer, Alexander Schmelzer, Andreas Trapp, Stephen Will
  • Publication number: 20160230208
    Abstract: The present invention provides a method for the amplification of at least a first and a second target nucleic acid that may be present in a fluid sample. The invention further provides a kit and an analytical system for carrying out said amplification.
    Type: Application
    Filed: September 30, 2015
    Publication date: August 11, 2016
    Inventors: Meike Eickhoff, Niclas Hitziger, Anke Mussmann, Thomas W. Myers, Christopher Newhouse, Nicholas Newton, John Niemiec, Nancy Schoenbrunner, Edward S. Smith, Stephen Will, Heike Wilts, Dirk Zimmerman
  • Patent number: 9410195
    Abstract: The present invention provides reagents for use in the amplification of nucleic acids. Amplification carried out using oligonucleotides containing modified nucleotides can result in less non-specific amplification compared to amplification carried out using unmodified oligonucleotides.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: August 9, 2016
    Assignee: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Veeraiah Bodepudi, Nancy Schoenbrunner, Stephen Will
  • Publication number: 20160115529
    Abstract: The present invention concerns the amplification of at least a first and a second target nucleic acid that may be present in at least one fluid sample using an internal control nucleic acid for qualitative and/or quantitative purposes.
    Type: Application
    Filed: January 11, 2016
    Publication date: April 28, 2016
    Inventors: Meike Eickhoff, Ellen Fiss, Joachim Glaubitz, Niclas Hitziger, Stephen Will, Dirk Zimmerman
  • Patent number: 9238832
    Abstract: The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, having an internally-placed selective nucleotide complementary to only one variant of the target sequence wherein the allele-specific oligonucleotide is extended by a nucleic acid polymerase predominantly or exclusively when hybridized to the variant of the target sequence for which it has said complementary selective nucleotide.
    Type: Grant
    Filed: December 8, 2010
    Date of Patent: January 19, 2016
    Assignee: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Stephen Will, Alison Tsan, Nicolas Newton
  • Publication number: 20150322502
    Abstract: The present invention provides reagents for use in the amplification of nucleic acids. Amplification carried out using oligonucleotides containing modified nucleotides can result in less non-specific amplification compared to amplification carried out using unmodified oligonucleotides.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Inventors: Veeraiah Bodepudi, Nancy Schoenbrunner, Stephen Will
  • Patent number: 9115394
    Abstract: The present invention provides methods and reagents for use in the amplification of nucleic acids. Amplification carried out using oligonucleotides containing modified nucleotides can result in less non-specific amplification compared to amplification carried out using unmodified oligonucleotides.
    Type: Grant
    Filed: December 11, 2012
    Date of Patent: August 25, 2015
    Assignee: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Veeraiah Bodepudi, Nancy Schoenbrunner, Stephen Will
  • Patent number: 8614071
    Abstract: The present invention relates to a method, oligonucleotides, reaction mixtures and kits for the selective amplification of a messenger RNA target comprising an exon-exon junction, using an oligonucleotide that comprises at least one nucleotide modified at the exocyclic amino group.
    Type: Grant
    Filed: December 8, 2010
    Date of Patent: December 24, 2013
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Stephen Will, Lori Steiner, Alison Tsan, Nicolas Newton
  • Patent number: 8163487
    Abstract: The present invention provides methods of extending primer nucleic acids and sequencing target nucleic acids. The methods include the use of 2?-terminator nucleotides to effect chain termination. In addition to related reaction mixtures and kits, the invention also provides computers and computer readable media.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: April 24, 2012
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David Harrow Gelfand, Fred Lawrence Reichert, Veeraiah Bodepudi, Amar Gupta, Stephen Will, Thomas W. Myers
  • Publication number: 20110312040
    Abstract: The present invention relates to a method, oligonucleotides, reaction mixtures and kits for the selective amplification of a messenger RNA target comprising an exon-exon junction, using an oligonucleotide that comprises at least one nucleotide modified at the exocyclic amino group.
    Type: Application
    Filed: December 8, 2010
    Publication date: December 22, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Stephen Will, Lori Steiner, Alison Tsan, Nicolas Newton
  • Publication number: 20110311968
    Abstract: The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, having an internally-placed selective nucleotide complementary to only one variant of the target sequence wherein the allele-specific oligonucleotide is extended by a nucleic acid polymerase predominantly or exclusively when hybridized to the variant of the target sequence for which it has said complementary selective nucleotide.
    Type: Application
    Filed: December 8, 2010
    Publication date: December 22, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Stephen Will, Alison Tsan, Nicolas Newton
  • Publication number: 20110212991
    Abstract: The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting, patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor.
    Type: Application
    Filed: January 27, 2011
    Publication date: September 1, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Rachel Langland, Lin Wu, Thad Sharp, Stephen Will
  • Publication number: 20110201002
    Abstract: The present invention provides methods of extending primer nucleic acids and sequencing target nucleic acids. The methods include the use of 2?-terminator nucleotides to effect chain termination. In addition to related reaction mixtures and kits, the invention also provides computers and computer readable media.
    Type: Application
    Filed: March 10, 2011
    Publication date: August 18, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: David Harrow Gelfand, Fred Lawrence Reichert, Veeraiah Bodepudi, Amar Gupta, Stephen Will, Thomas Myers
  • Patent number: 7919249
    Abstract: The present invention provides methods of extending primer nucleic acids and sequencing target nucleic acids. The methods include the use of 2?-terminator nucleotides to effect chain termination. In addition to related reaction mixtures and kits, the invention also provides computers and computer readable media.
    Type: Grant
    Filed: July 16, 2008
    Date of Patent: April 5, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David Harrow Gelfand, Fred Lawrence Reichert, Veeraiah Bodepudi, Amar Gupta, Stephen Will, Thomas Myers